Peter Pitts from the Center for Medicine in the Public Interest comments on the Wyeth Decision. He says it's great for trial lawyers but ultimately bad for consumers. Drug labeling will become much more complex and drug innovation will be hindered.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…